NuvoAir

NuvoAir provides a virtual-first specialty care model focused on proactive diagnosis and ongoing management of complex heart and lung conditions. Their approach combines remote consultations with specialists, at-home diagnostic devices such as spirometers and pulse oximeters, AI-driven patient monitoring tools to predict exacerbations or complications early, and comprehensive practice management solutions for providers. The company reports over seventy publications demonstrating improved outcomes in chronic cardiopulmonary patients through their model. They partner with health plans, risk-bearing entities, biopharma companies, CROs/clinical research organizations as well as individual clinics to deliver value-based care at scale.